keyword
https://read.qxmd.com/read/38621440/hepatic-infarction-in-pregnancy-a-systematic-review
#1
REVIEW
Bryce T Munter, Angela R Boyd, Raphaela Tchani, Jordan N Gray, Patrick S Ramsey
OBJECTIVE: Hepatic infarction is a rare complication of pregnancy most often associated with hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome. The objective of this review is to identify risk factors, presenting signs and symptoms, methods of diagnosis, and best management practices based on published case reviews. DATA SOURCES: PUBMED and MEDLINE: OVID databases were searched for citations regarding hepatic infarction in pregnancy or the postpartum period since database inception until the study date of December 18, 2023...
April 13, 2024: American journal of obstetrics & gynecology MFM
https://read.qxmd.com/read/38611066/management-of-portal-hypertension-in-patients-with-hepatocellular-carcinoma-on-systemic-treatment-current-evidence-and-future-perspectives
#2
REVIEW
Valeria De Gaetano, Maria Pallozzi, Lucia Cerrito, Francesco Santopaolo, Leonardo Stella, Antonio Gasbarrini, Francesca Romana Ponziani
The management of CSPH in patients undergoing systemic treatment for HCC has emerged as a critical concern due to the absence of reliable diagnostic criteria and uncertainties surrounding therapeutic approaches. This review aims to underscore the primary pathophysiological aspects linking HCC and PH, while also addressing the current and emerging clinical strategies for the management of portal hypertension. A review of studies from January 2003 to June 2023 was conducted using the PubMed database and employing MeSH terms, such as "hepatocellular carcinoma", "immune checkpoint inhibitors", "systemic therapy", "portal hypertension", "variceal bleeding" and "tyrosine kinase inhibitors"...
March 31, 2024: Cancers
https://read.qxmd.com/read/38609052/heart-failure-the-global-pandemic-a-call-to-action-consensus-statement-from-the-global-presidential-conclave-at-the-platinum-jubilee-conference-of-cardiological-society-of-india-2023
#3
REVIEW
S Harikrishnan, Prathap Chandra Rath, Vijay Bang, Theresa McDonagh, Elijah Ogola, Hugo Silva, Bijoy G Rajbanshi, Anidu Pathirana, G Andre Ng, Cathleen Biga, Thomas F Lüscher, Ramesh Daggubati, Shirley Adivi, Debabrata Roy, P S Banerjee, M K Das
Heart failure (HF) is emerging as a major public health problem both in high- and low - income countries. The mortality and morbidity due to HF is substantially higher in low-middle income countries (LMICs). Accessibility, availability and affordability issues affect the guideline directed therapy implementation in HF care in those countries. This call to action urges all those concerned to initiate preventive strategies as early as possible, so that we can reduce HF-related morbidity and mortality. The most important step is to have better prevention and treatment strategies for diseases such as hypertension, ischemic heart disease (IHD), type-2 diabetes, and rheumatic heart disease (RHD) which predispose to the development of HF...
April 10, 2024: Indian Heart Journal
https://read.qxmd.com/read/38606558/positive-vasoreactivity-testing-in-pulmonary-arterial-hypertension-therapeutic-consequences-treatment-patterns-and-outcomes-in-the-modern-management-era
#4
JOURNAL ARTICLE
Felix Gerhardt, Eva Fiessler, Karen M Olsson, Moritz Z Kayser, Gabor Kovacs, Henning Gall, H Ardeschir Ghofrani, Roza Badr Eslam, Irene M Lang, Nicola Benjamin, Ekkehard Grünig, Michael Halank, Tobias J Lange, Silvia Ulrich, Hanno Leuchte, Matthias Held, Hans Klose, Ralf Ewert, Heinrike Wilkens, Carmen Pizarro, Dirk Skowasch, Max Wissmüller, Martin Hellmich, Horst Olschewski, Marius M Hoeper, Stephan Rosenkranz
BACKGROUND: Among patients with pulmonary arterial hypertension (PAH), acute vasoreactivity testing during right heart catheterization may identify acute vasoresponders, for whom treatment with high-dose calcium channel blockers (CCBs) is recommended. However, long-term outcomes in the current era remain largely unknown. We sought to evaluate the implications of acute vasoreactivity response for long-term response to CCBs and other outcomes. METHODS: Patients diagnosed with PAH between January 1999 and December 2018 at 15 pulmonary hypertension centers were included and analyzed retrospectively...
April 12, 2024: Circulation
https://read.qxmd.com/read/38605571/surgical-versus-medical-management-of-patients-with-primary-hyperaldosteronism-and-indeterminate-adrenal-vein-sampling-a-10-year-experience-of-the-cleveland-clinic
#5
JOURNAL ARTICLE
Chineme Onwubueke, Saif M Borgan, Huijun Xiao, Keren Zhou
In patients with primary hyperaldosteronism (PA), adrenal vein sampling (AVS) can identify patients suitable for unilateral adrenalectomy. However, in AVS with an indeterminate aldosterone-to-cortisol lateralization (ACL) ratio of 3.0-4.0, clinical guidance is unclear. The authors screened all patients undergoing AVS at the Cleveland Clinic from October 2010 to January 2021 and identified 18 patients with indeterminate ACL results. Ten underwent adrenalectomy and eight continued medical management. The surgical group was younger (58...
April 11, 2024: Journal of Clinical Hypertension
https://read.qxmd.com/read/38604225/outpatient-management-of-essential-hypertension-a-review-based-on-the-latest-clinical-guidelines
#6
REVIEW
Areesha Moiz, Tetiana Zolotarova, Mark J Eisenberg
Background: Essential hypertension, a prevalent cardiovascular condition, poses a significant health burden worldwide. Based on the latest American clinical guidelines, half of adults in the United States have hypertension. Of these, only about a half are treated and about a quarter are adequately controlled for hypertension. Given its impact on morbidity and mortality, ensuring effective management of high blood pressure is crucial to reduce associated risks and improve patient outcomes. Objective: This review aims to provide a comprehensive and up-to-date summary of the latest cardiology guidelines and evidence-based research on essential hypertension, with a focus on guiding outpatient clinical practice...
December 2024: Annals of Medicine
https://read.qxmd.com/read/38603658/real-world-evidence-of-ribociclib-plus-aromatase-inhibitors-as-first-line-treatment-in-advanced-breast-cancer-the-brasileeira-study
#7
JOURNAL ARTICLE
Daniele Assad Suzuki, Alessandra Menezes Morelle, Mayana Lopes de Brito, Flavia Rocha Paes, André Mattar, Jorge H Santos Leal, Sérgio D Simon, Ellias Magalhães Abreu Lima, Gustavo Werutsky, Gustavo H Munhoz Piotto, José Bines, Lucas Petri Damiani, Ariane Macedo, Lígia Campos, Anna Maria Buehler
PURPOSE: Cyclin inhibitors plus endocrine therapy represent the reference standard for hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) locally advanced or metastatic breast cancer (ABC). Efficacy results on hard end points such as overall survival come from well-designed randomized clinical trials (RCTs). However, a limitation of RCTs is the low external results validity, and their extrapolation to a broader population may not be appropriate. Real-world studies can overcome these limitations, also increasing the reliability of RCTs...
April 2024: JCO global oncology
https://read.qxmd.com/read/38600678/type-a-aortic-dissection-after-coronary-artery-bypass-grafting
#8
JOURNAL ARTICLE
Vusal Hajiyev, Murad Qubadov, Leyla Maharramova, Gulnaz Dadashova, Asiman Hasanov
BACKGROUND Aortic dissection is rare after coronary artery bypass grafting (CABG). It is a potentially fatal complication of cardiac surgery. Reoperation may pose problems with thoracotomy, adhesiolysis, and myocardial protection. No standard treatment guidelines exist for chronic aortic dissection after CABG. We present a case of chronic type A aortic dissection after cardiac surgery, which was successfully treated. CASE REPORT A 65-year-old female patient presented with a medical background of hypertension, type 2 diabetes mellitus, and hyperlipidemia...
April 11, 2024: American Journal of Case Reports
https://read.qxmd.com/read/38600006/guidelines-for-the-management-of-coagulation-disorders-in-patients-with-cirrhosis
#9
I Aiza-Haddad, L E Cisneros-Garza, O Morales-Gutiérrez, R Malé-Velázquez, M T Rizo-Robles, R Alvarado-Reyes, L A Barrientos-Quintanilla, F Betancourt-Sánchez, E Cerda-Reyes, R Contreras-Omaña, M B Dehesa-Violante, N C Flores-García, D Gómez-Almaguer, M F Higuera-de la Tijera, M A Lira-Pedrin, J E Lira-Vera, H Manzano-Cortés, D E Meléndez-Mena, M R Muñoz-Ramírez, J L Pérez-Hernández, M V Ramos-Gómez, J F Sánchez-Ávila
Coagulation management in the patient with cirrhosis has undergone a significant transformation since the beginning of this century, with the concept of a rebalancing between procoagulant and anticoagulant factors. The paradigm that patients with cirrhosis have a greater bleeding tendency has changed, as a result of this rebalancing. In addition, it has brought to light the presence of complications related to thrombotic events in this group of patients. These guidelines detail aspects related to pathophysiologic mechanisms that intervene in the maintenance of hemostasis in the patient with cirrhosis, the relevance of portal hypertension, mechanical factors for the development of bleeding, modifications in the hepatic synthesis of coagulation factors, and the changes in the reticuloendothelial system in acute hepatic decompensation and acute-on-chronic liver failure...
April 9, 2024: Revista de Gastroenterología de México
https://read.qxmd.com/read/38599560/high-output-cardiac-state-evaluating-the-incidence-plausible-etiologies-and-outcomes
#10
REVIEW
Hilary Bews, Sangyang Jia, Yixiu Liu, Jaime Sklar, John Ducas, Iain Kirkpatrick, James W Tam, Ashish H Shah
INTRODUCTION: The high output cardiac state (HOCS) [cardiac index (CI) >4 L/min/m2 ], primarily driven by abnormally low systemic vascular resistance (SVR), is a relatively under-recognized condition. Although, majority of these patients meet criteria for heart failure (HF), their treatment should be aimed at the primary pathology, as the majority of guideline directed HF therapies can reduce SVR further. OBJECTIVES: To characterize patients with HOCS and provide valuable insight into the condition...
April 8, 2024: Current Problems in Cardiology
https://read.qxmd.com/read/38597065/%C3%AE-blockers-are-not-all-the-same-pharmacologic-similarities-and-differences-potential-combinations-and-clinical-implications
#11
REVIEW
Stefano Taddei, Nqoba Tsabedze, Ru-San Tan
β-blockers are a heterogeneous class, with individual agents distinguished by selectivity for β1 - vs. β2 - and α-adrenoceptors, presence or absence of partial agonist activity at one of more β-receptor subtype, presence or absence of additional vasodilatory properties, and lipophilicity, which determines the ease of entry the drug into the central nervous system. Cardioselectivity (β1 -adrenoceptor selectivity) helps to reduce the potential for adverse effects mediated by blockade of β2 -adrenoceptors outside the myocardium, such as cold extremities, erectile dysfunction, or exacerbation of asthma or chronic obstructive pulmonary disease...
2024: Current Medical Research and Opinion
https://read.qxmd.com/read/38596498/optimizing-nutrition-in-hepatic-cirrhosis-a-comprehensive-assessment-and-care-approach
#12
REVIEW
Osvely Mendez-Guerrero, Anaisa Carranza-Carrasco, Luis Alberto Chi-Cervera, Aldo Torre, Nalu Navarro-Alvarez
Cirrhosis is considered a growing cause of morbidity and mortality, which represents a significant public health problem. Currently, there is no effective treatment to reverse cirrhosis. Treatment primarily centers on addressing the underlying liver condition, monitoring, and managing portal hypertension-related complications, and evaluating the potential for liver transplantation in cases of decompensated cirrhosis, marked by rapid progression and the emergence of complications like variceal bleeding, hepatic encephalopathy, ascites, malnutrition, and more...
March 14, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38594665/on-demand-mobile-hypertension-training-for-primary-health-care-workers-in-nigeria-a-pilot-study
#13
JOURNAL ARTICLE
Joseph Odu, Kufor Osi, Leander Nguyen, Allison Goldstein, Lawrence J Appel, Kunihiro Matsushita, Dike Ojji, Ikechukwu A Orji, Morenike Alex-Okoh, Deborah Odoh, Malau Mangai Toma, Chris Ononiwu Elemuwa, Suleiman Lamorde, Hasana Baraya, Mary T Dewan, Obagha Chijioke, Andrew E Moran, Emmanuel Agogo, Marshall P Thomas
BACKGROUND: Only one out of every ten Nigerian adults with hypertension has their blood pressure controlled. Health worker training is essential to improve hypertension diagnosis and treatment. In-person training has limitations that mobile, on-demand training might address. This pilot study evaluated a self-paced, case-based, mobile-optimized online training to diagnose and manage hypertension for Nigerian health workers. METHODS: Twelve hypertension training modules were developed, based on World Health Organization and Nigerian guidelines...
April 9, 2024: BMC Health Services Research
https://read.qxmd.com/read/38592220/transjugular-intrahepatic-portosystemic-shunt-in-nonmalignant-noncirrhotic-portal-vein-thrombosis-and-portosinusoidal-vascular-disorder
#14
REVIEW
Sarah Shalaby, Roberto Miraglia, Marco Senzolo
Transjugular intrahepatic portosystemic shunt (TIPS) emerges as a key treatment for portal hypertension (PH) complications. While international guidelines provide clear indications for its use in cirrhosis, empirical knowledge is notably scarcer in non-cirrhotic PH, particularly in nonmalignant noncirrhotic portal vein thrombosis (NNPVT) and in patients with portosinusoidal vascular disorder (PSVD). Patients afflicted by these rare diseases exhibit distinct clinical profiles compared to their cirrhotic counterparts, often characterized by a younger age, predominantly preserved hepatic functionality even in cases of severe PH, and a higher propensity for extensive splanchnic thrombosis, which intricately complicates TIPS placement, posing unique challenges for its creation...
February 29, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38591289/challenges-and-technical-aspects-in-the-management-of-muscle-invasive-bladder-cancer-as-retrograde-radical-cystectomy-with-ileal-conduit
#15
JOURNAL ARTICLE
Nadeem Bin Nusrat, Assad Ur Rehman, Nauman Zafar, Shujah Muhammad, Sarmad Imtiaz Bajwa, Saira Imtiaz
OBJECTIVE: To evaluate long-term outcomes in patients homogenously treated with radical cystectomy and ileal conduit for muscle invasive bladder cancer. METHODS: The retrospective study was conducted at the Urology Department of Pakistan Kidney and Liver Institute and Research Centre, Lahore, Pakistan, and comprised data from December 25, 2017, to January 16, 2023, related to patients who underwent radical cystectomy with ileal conduit with or without neo-adjuvant and adjuvant radiation, chemotherapy, or immunotherapy for papillary urothelial carcinom of the bladder...
March 2024: JPMA. the Journal of the Pakistan Medical Association
https://read.qxmd.com/read/38590611/the-prevalence-of-cardiovascular-diseases-chronic-kidney-disease-and-obesity-in-patients-with-type-2-diabetes-mellitus-and-the-description-of-concurrent-treatments-a-two-center-retrospective-cross-sectional-study-in-saudi-arabia
#16
JOURNAL ARTICLE
Omar A Alshaya, Ghazwa B Korayem, Munirah Alghwainm, Wed Alyami, Albandari Alotaibi, Majed S Alyami, Omar A Almohammed
BACKGROUND: Atherosclerotic cardiovascular disease (ASCVD), heart failure (HF), chronic kidney disease (CKD), and obesity are associated with increased morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). Nonetheless, their prevalence among patients with T2DM in Saudi Arabia (SA) remains unknown. As current guidelines recommend, these comorbidities require adding certain antidiabetic agents with cardiorenal benefits. However, the prescribers' adherence to these recommendations remains unclear...
May 2024: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
https://read.qxmd.com/read/38590317/exploring-primary-care-physicians-challenges-in-using-home-blood-pressure-monitoring-to-manage-hypertension-in-singapore-a-qualitative-study
#17
JOURNAL ARTICLE
Aminath Shiwaza Moosa, Prawira Oka, Chirk Jenn Ng
OBJECTIVE: Hypertension guidelines recommend using home blood pressure (HBP) to diagnose, treat and monitor hypertension. This study aimed to explore the challenges primary care physicians (PCPs) face in using HBP to manage patients with hypertension. METHOD: A qualitative study was conducted in 2022 at five primary care clinics in Singapore. An experienced qualitative researcher conducted individual in-depth interviews with 17 PCPs using a semi-structured interview guide...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38590072/future-directions-and-innovations-in-venous-sinus-stenting
#18
REVIEW
Abhinav Pandey, Craig Schreiber, Andrew L A Garton, Brandon Jung, Jacob L Goldberg, Gary Kocharian, Joseph A Carnevale, Srikanth R Boddu
This review explores the future role of venous sinus stenting (VSS) in the management of idiopathic intracranial hypertension and pulsatile tinnitus. Despite its favorable safety profile and clinical outcomes compared with traditional treatments, VSS is not yet the standard of care for these conditions, lacking high-level evidence data and guidelines for patient selection and indications. Current and recently completed clinical trials are expected to provide data to support the adoption of VSS as a primary treatment option...
April 2024: World Neurosurgery
https://read.qxmd.com/read/38589945/aspiration-of-thrombus-for-intermediate-risk-subacute-pulmonary-embolism
#19
JOURNAL ARTICLE
Jiahao He, Chunli Liu
Pulmonary embolism is the most common cardiovascular disease after myocardial infarction and stroke. Konstantinides (Eur Heart J 41(4):543-603, 2020) Current guidelines categorize patients with PE as being at low, intermediate, and high risk of early death, with the intermediate-risk group experiencing the greatest uncertainty regarding treatment recommendations. Rapid reduction of the thrombus load by thrombolysis significantly reduces symptoms and decreases mortality, but is accompanied by a high risk of bleeding...
April 8, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38588936/opportunities-and-limitations-of-renal-denervation-where-do-we-stand
#20
REVIEW
Beatriz Castillo Rodriguez, Eric A Secemsky, Rajesh V Swaminathan, Dmitriy N Feldman, Markus Schlaich, Yuri Battaglia, Edward Filippone, Chayakrit Krittanawong
Hypertension is a primary contributor to cardiovascular disease, and the leading risk factor for loss of quality adjusted life years. Up to 50% of the cases of hypertension in the US remain uncontrolled. Additionally, 8-18% of the hypertensive population have resistant hypertension, uncontrolled pressure despite three different anti-hypertensive agents. Recently, catheter-based, percutaneous renal denervation emerged as a method for ablating renal sympathetic nerves for difficult to control hypertension. Initial randomized (non-sham) trials and registry analyses showed impressive benefit, but the first sham-controlled randomized controlled trial (RCT) using monopolar radiofrequency ablation showed limited benefit...
April 6, 2024: American Journal of Medicine
keyword
keyword
163823
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.